Drug intelligence / Profile preview

isatin

Development stage
Unknown
Modality
Small Molecules
01

Overview

Isatin is a small molecule and an indole derivative with the chemical formula C8H5NO2. It was first discovered in 1841 as an oxidation product of indigo dye. Structurally, it consists of a fused benzene ring and a five-membered nitrogen-containing ring (indole core) with carbonyl groups at positions 2 and 3. Isatin acts as both an electrophile and nucleophile in organic synthesis due to its unique reactivity profile[1][3][6]. It has been widely used as a building block for pharmaceuticals, dyes, and other organic compounds. Biologically, isatin exhibits monoamine oxidase (MAO) inhibitory activity—particularly against MAO-B—which can increase dopamine levels in the brain[1][6]. Derivatives of isatin have been investigated for potential anticonvulsant, antitumor, antibacterial, antifungal, antitubercular, antiviral activities among others[6]. However, isatin itself has not been approved for clinical use as a pharmaceutical drug but remains important in medicinal chemistry research.

Other names
1H-indole-2,3-dione2,3-indolinedionetribulin2,3-dioxoindolineindenedioneindole quinone
02

Targets

MAOA (Monoamine oxidase A)MAOB (Monoamine oxidase B)

Beyond the preview

Go deeper on isatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isatin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call